More than 20% of patients with systemic neoplasia will develop neurological symptoms and signs (Figure 1)1 and between 7-15% of these are due to nonmetastatic complications. If diagnosed early, many nonmetastatic manifestations are reversible, but if not, they impair quality of life and are potentially rapidly fatal.
Posner JBNeurological complications of systemic cancer. Med Clin North Am1979; 63: 783-80.
2.
Henson RA, Urich H.Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Volume 14. Oxford: Blackwell Scientific, 1987 ; 314-345.
3.
Graus F., Elkon KB, Lloberes P. et al. Neuronal antinuclear antibody (Anti-Hu) in paraneoplastic encephalomyelitis simulating acute polyneuritis. Acta Neurol Scand1987; 75: 249-52.
4.
Jaeckle KA, Graus F., Houston A., Cardon-Cardo C., Nielsen SL, Posner JBAutoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasm protein antigen. Ann Neurol1985; 18: 592-600.
5.
Ross AT, Zeman W.Opsoclonus, occult carcinoma, and chemical pathology in the dentate nuclei . Arch Neurol1967; 17: 546-51.
6.
Babikian VL, Stefansson K., Dieperink ME, Arnason Bgw, Marton LS, Levy BEParaneoplastic myelopathy: antibodies against protein in normal spinal cord and underlying neoplasm. Lancet1985; 2: 49-50.
7.
Julien J., Vital C., Aupy G. et al. GuillainBarre Syndrome and Hodgkin's disease. Ultrastructural study of a peripheral nerve. J Neurol Sci1980; 45: 23-27.
8.
Graus F., Elkon KB, Cordon-Cardo C., Posner JBSensory neuronopathy and small cell cancer: antineuronal antibody that also reacts with the tumour. Am Med J1986; 80: 45-52.
9.
Lang B., Newsom-Davis J., Wray D. et al. Autoimmune aetiology for myaesthenic (Eaton Lambert) syndrome. Lancet1981; 2: 224-26.
10.
Lindstrom JM , Lambert EHContent of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton-Lambert syndrome. Neurology ( NY) 1978; 28 (2): 130-38.
11.
Whitaker JNInflammatory myopathy; a review of aetiologic and pathogenic factors. Muscle Nerve1982; 5: 573-76.
12.
Anderson NE , Rosenblum MK, Graus F., Wiley RG, Posner JBAutoantibodies in paraneoplastic syndromes associated with small cell lung cancer. Neurology1988; 38: 1391-98.
Smith JL, Finlay JC, Lennon VAAutoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes. J Neuroimmunol1988; 18: 37-48.
15.
Henson RA, Urich H.Cancer and the nervous system: the neurological manifestations of systemic malignant disease. Volume 15. Oxford: Blackwell Scientific Publications, 1987: 346-67.
16.
Brandt S., Carlsen N., Glenting P. et al. Encephalopathia myoclonica infantile (Kinsbourne) and neuroblastoma in children: a report of 3 cases. Dev Med Child Neurol1974; 16: 286-94.
17.
Altman AJ, Baehner RLFavourable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer1976; 37 (2): 846-52.
18.
Senelick RC , Bray PF, Lahey ME et al. Neuroblastoma and myoclonic encephalopathy: Two cases and a review of the literature. J Paediatr Surg1973; 8: 623-32.
19.
Julien J., Vital C., Aupy G., Lagueny A., Darriet D., Brechenmacher D.Guillain-Barre syndrome and Hodgkins disease. Ultrastructural study of a peripheral nerve. J Neurol Sci1980; 45: 23-27.
20.
Lundh H., Nilsson O., Rosen I.Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine . Neurology1984; 34: 1324-30.
21.
Brown JC, Johns RJDiagnostic difficulties encountered in the myaesthenic syndrome sometimes associated with carcinoma. J Neurol Neurosurg Psychiatry1974; 37: 1214-24.
22.
Barnes BEDermatomyositis and malignancy. A review of the literature. Ann Intern Med1976; 84: 68-76.
23.
Bohan A., Peter JPPolymyositis and dermatomyositis. N Engl J Med1975; 292: 344-47.
24.
Bunch TWPrednisolone and azathioprine for polymyositis: Long term follow-up. Arthritis Rheum1981; 24: 45-48.
25.
Editorial.ACTH secreting tumours. Br Med J1977; 1: 1047-48.
26.
Heath DAHypercalcaemia of malignancy. Palliative Medicine1989; 3: 1-11.
27.
Swash M., Fox KP, Davidson ARCarcinoid myopathy: Serotonin induced muscle weakness in man. Arch Neurol1975; 32: 572-4.
28.
Peters Acb, Versteeg J, BotsGTAM, Boogerd W, Vielvoye GJ. Progressive multifocal leukoencephalopathy: Immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol1980; 37: 497-501.
